Michael G. Grey, Director at Mirati Therapeutics, Inc. (MRTX), sold 6,084 shares at $102.44 ($623K) on 2019-11-12, disclosed to the SEC on 2019-11-14.
Open-market sale of $623k MRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $102.44 | 3,042 | $312K | 50.0% |
| 2 | $102.44 | 3,042 | $312K | 50.0% |
| Total | $102.44 avg | 6,084 | $623K | 100% |
| Filing → |
| MIRM | SELL | 2025-11-25 | $3.5M | — | Filing → |
| MIRM | SELL | 2023-09-14 | $467K | — | Filing → |
| MIRM | SELL | 2023-06-09 | $424K | — | Filing → |